Highlights
A new drug target for liver cancer
February 04, 2021NUS researchers have discovered that the MOAP-1 protein plays a role in reducing liver cancer risk by suppressing the hyper-active…
Read More
Cyclic peptides for cancer therapy and prognosis assessment
September 28, 201828 Sep 2018. NUS biologists have developed cyclic peptides that can trigger cancer cell death without affecting healthy cells. The…
Read More
Non-sex hormones in sexing liver cancers
August 07, 20177 Aug 2017. NUS biologists have discovered that two hormone factors, cortisol and serotonin, play critical roles in the development of…
Read More
Targeting cell-surface GRP78 for cancer therapy
March 17, 201717 Mar 2017. NUS biologists have developed small peptides which are able to target cancer cells for anti-cancer therapeutics. Cancer is…
Read More